openPR Logo
Press release

Sunitinib Drug Market Size, Share, Development by 2024

02-26-2019 03:06 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Info Research

Global Info Research offers a latest published report on Sunitinib Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-sunitinib-drug-market_p103889.html
 
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. 

Scope of the Report:
The global Sunitinib Drug market is valued at x million USD in 2018 and is expected to reach x million USD by the end of 2024, growing at a CAGR of x% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sunitinib Drug.
Europe also play important roles in global market, with market size of x million USD in 2019 and will be x million USD in 2024, with a CAGR of x%.
This report studies the Sunitinib Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sunitinib Drug market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Pfizer

Market Segment by Type, covers
    12.5 mg Capsules
    25 mg Capsules
    37.5 mg Capsules
    50 mg Capsules

Market Segment by Applications, can be divided into
    Kidney cancer
    GIST
    pNET

For More Information On This Report, Please Visit @
https://www.globalinforesearch.com/global-sunitinib-drug-market_p103889.html

Key Reasons to Purchase:
• To gain insightful analyses of the market and have a comprehensive understanding of the Sunitinib Drug Market and its commercial landscape.
• Learn about the market strategies that are being adopted by your competitors and leading organizations.
• To understand the future outlook and prospects for Sunitinib Drug Market analysis and forecast 2019- 2025.

Customization Service of the Report :
Global Info Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US :
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sunitinib Drug Market Size, Share, Development by 2024 here

News-ID: 1615440 • Views: 194

More Releases from Global Info Research

Global Industrial Plasma Cutters Market: Size,Share,Analysis,Regional Outlook an …
Global Info Research offers a latest published report on Industrial Plasma Cutters Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Industrial Plasma Cutters players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Smart Valve Positioners Market: Size,Share,Analysis,Regional Outlook and …
Global Info Research offers a latest published report on Smart Valve Positioners Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Smart Valve Positioners players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Food Tray Sealing Machines Market: Size,Share,Analysis,Regional Outlook a …
Global Info Research offers a latest published report on Food Tray Sealing Machines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Food Tray Sealing Machines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report
Global Floor Scrubbing Machines Market: Size,Share,Analysis,Regional Outlook and …
Global Info Research offers a latest published report on Floor Scrubbing Machines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Floor Scrubbing Machines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure

All 5 Releases


More Releases for Sunitinib

Sunitinib Malate Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/sunitinib-malate-market/71802 The global market size of Sunitinib Malate is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,
Sunitinib Malate Capsules Market Research Report | Key Trends and Opportunity An …
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the
Sunitinib Malate Market | Key Trends and Forecast Research Report 2024
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the
Sunitinib Malate Capsules Market - Global Industry Analysis 2024
Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the U.S. FDA’s approval for use
Sunitinib Malate Capsules Market grows with increasing prevalence of pancreatic …
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the
Sunitinib Malate Capsules Market grows with increasing prevalence of pancreatic …
Global Sunitinib Malate Capsules Market: Overview Sunitinib malate is a small-molecule medicine that has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). The potential antineoplastic activity of sunitinib has led to it being regarded as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treating pancreatic neuroendocrine tumors, kidney cancer, and gastrointestinal stromal tumor (GIST). Sunitinib malate capsules received the